Pharmacokinetic, metabolism and withdrawal time of orphenadrine in camels (Camelus dromedarius) after intravenous administration.
M Elghazali, I A Wasfi, A A Abdel Hadi, A M Latum
Index: Res. Vet. Sci. 85(3) , 563-9, (2008)
Full Text: HTML
Abstract
The pharmacokinetics of orphenadrine (ORPH) following a single intravenous (i.v.) dose was investigated in six camels (Camelus dormedarius). Orphenadrine was extracted from the plasma using a simple sensitive liquid-liquid extraction method and determined by gas chromatography/mass spectrometry (GC/MS). Following i.v. administration plasma concentrations of ORPH decline bi-exponentially with distribution half-life (t(1/2)(alpha)) of 0.50+/-0.07h, elimination half-life (t(1/2)(beta)) of 3.57+/-0.55h, area under the time concentration curve (AUC) of 1.03+/-0.10g/hl(-1). The volume of distribution at steady state (Vd(ss)) 1.92+/-0.22lkg(-1), volume of the central compartment of the two compartment pharmacokinetic model (V(c)) 0.87+/-0.09lkg(-1), and total body clearance (Cl(T)) of 0.60+/-0.09l/hkg(-1). Three orphenadrine metabolites were identified in urine samples of camels. The first metabolite N-desmethyl-orphenadrine resulted from N-dealkylation of ORPH with molecular ion m/z 255. The second N,N-didesmethyl-orphenadrine, resulted from N-didesmethylation with molecular ion m/z 241. The third metabolite, hydroxyl-orphenadrine, resulted from the hydroxylation of ORPH with molecular ion m/z 285. ORPH and its metabolites in camel were extensively eliminated in conjugated form. ORPH remains detectable in camel urine for three days after i.v. administration of a single dose of 350mg orphenadrine aspartate.
Related Compounds
Related Articles:
2014-05-01
[Exp. Neurol. 255 , 96-102, (2014)]
2012-01-01
[Audiol. Neurootol. 17(3) , 179-88, (2012)]
2007-12-01
[Naunyn Schmiedebergs Arch. Pharmacol. 376(4) , 275-84, (2007)]
2012-01-01
[Chem. Pharm. Bull. 60(11) , 1426-36, (2012)]
2009-01-01
[J. Pharm. Pharmacol. 61(1) , 47-54, (2009)]